A team of researchers from UWA and the University of Birmingham in England are exploring the possibility of redesigning ecstasy, or MDMA, to treat blood cancer.

Previous research has shown that compounds similar to ecstasy kill cell-lines derived from blood cancers such as lymphoma, leukaemia, and myeloma. MDMA has been modified to eliminate the ecstatic sensation of high while at the same time their potency against cancer cells has been boosted more than 100 times.

Work is still ongoing to discover even more successful compounds and possible drug candidates.

Source: University of Western Australia